These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12723562)

  • 1. Guidelines for 131I-meta-iodobenzylguanidine therapy.
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP23-6. PubMed ID: 12723562
    [No Abstract]   [Full Text] [Related]  

  • 2. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.
    Giammarile F; Chiti A; Lassmann M; Brans B; Flux G;
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):1039-47. PubMed ID: 18274745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for 131I-ethiodised oil (Lipiodol) therapy.
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP20-2. PubMed ID: 12723561
    [No Abstract]   [Full Text] [Related]  

  • 4. EANM procedure guidelines for therapy with iodine-131.
    EANM
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP27-31. PubMed ID: 12723563
    [No Abstract]   [Full Text] [Related]  

  • 5. EANM procedure guidelines for 32P therapy.
    EANM
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP17-9. PubMed ID: 12723560
    [No Abstract]   [Full Text] [Related]  

  • 6. EANM procedure guidelines for radiosynovectomy.
    Clunie G; Fischer M;
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP12-6. PubMed ID: 12723558
    [No Abstract]   [Full Text] [Related]  

  • 7. EANM procedure guidelines for treatment of refractory metastatic bone pain.
    Silberstein EB; Taylor AT;
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP7-11. PubMed ID: 12723557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Draft guideline regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine].
    Kinuya S; Yoshinaga K; Higuchi T; Jinguji M; Kawamoto H; Kurihara H
    Kaku Igaku; 2015 Feb; 52(1):1-15. PubMed ID: 26502667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
    Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP132-9. PubMed ID: 14989227
    [No Abstract]   [Full Text] [Related]  

  • 10. [¹³¹I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies.
    Rachh SH; Abhyankar S; Basu S
    Nucl Med Commun; 2011 Dec; 32(12):1201-10. PubMed ID: 21968432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
    Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
    Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
    Gaze MN; Gains JE; Walker C; Bomanji JB
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):66-78. PubMed ID: 23474636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents.
    Mairs RJ
    Eur J Cancer; 1999 Aug; 35(8):1171-3. PubMed ID: 10615225
    [No Abstract]   [Full Text] [Related]  

  • 14. Draft guidelines regarding appropriate use of (131)I-MIBG radiotherapy for neuroendocrine tumors : Guideline Drafting Committee for Radiotherapy with (131)I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine.
    Kinuya S; Yoshinaga K; Higuchi T; Jinguji M; Kurihara H; Kawamoto H;
    Ann Nucl Med; 2015 Jul; 29(6):543-52. PubMed ID: 25773397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
    Bardiès M; Buvat I
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):5-20. PubMed ID: 21386782
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.
    Spetz J; Dalmo J; Nilsson O; Wängberg B; Ahlman H; Forssell-Aronsson E
    Horm Metab Res; 2012 May; 44(5):400-4. PubMed ID: 22566195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of an important typographical error in the European Association of Nuclear Medicine (EANM) guidelines.
    Anderson EA
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1080. PubMed ID: 22302091
    [No Abstract]   [Full Text] [Related]  

  • 18. [131I]MIBG radionuclide therapy in carcinoid syndrome.
    Taal BG; Zuetenhorst H; Valdés Olmos RA; Hoefnagel CA
    Eur J Surg Oncol; 2002 Apr; 28(3):243. PubMed ID: 11944956
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term efficacy of low activity meta-[131I]iodobenzylguanidine therapy in patients with disseminated neuroendocrine tumours depends on initial response.
    Buscombe JR; Cwikla JB; Caplin ME; Hilson AJ
    Nucl Med Commun; 2005 Nov; 26(11):969-76. PubMed ID: 16208174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
    Fullerton NE; Boyd M; Ross SC; Pimlott SL; Babich J; Kirk D; Zalutsky MR; Mairs RJ
    Med Chem; 2005 Nov; 1(6):611-8. PubMed ID: 16787344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.